Alvine Pharmaceuticals - Biopharmaceutical products for the treatment of celiac sprue.

Emphasys Medical develops minimal evasive therapies for Chronic Obstructive Pulmonary Disease.

Endomatrix has developed a platform for the treatment and prevention of endothelial-based disease states, delivered through both nutraceutical and pharmaceutical products.

Redpoint Bio (OTC: RPBC.OB) develops breakthrough products that improve the palatability of oral medicines and enhance the flavor and nutritional value of foods and beverages, including solutions to the problems of bitterness, excess sugar, and excess salt.

Acquired by Roche in June 2007, NimbleGen provides customized high-density microarray products and services for functional genomics experiments.

Sirtris Pharmaceuticals (NASDAQ: SIRT) drug discovery focused on class III histone deacetylases (sirtuins).